Market expert Raja Venkatraman shares his top three stock picks to buy today, 4 November. Discover his exclusive picks and ...

He pretended to be a Dubai resident who wanted to fly back, for which he wanted to undergo the mandatory RT-PCR test. But he ...

A third arm of eight cycles of Enhertu monotherapy was initially open but closed early when interim analysis showed a low probability ... reported that the Enhertu-THP arm of the trial reached a pCR ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 ...

Despite the weekly pullback, it's important to recognise that this appears to be a minor correction rather than a trend ...

In the past one month, Shriram Finance stock has outperformed the market by surging 23 per cent, as compared to 3.3 per cent ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

“The rapid expansion of PCR-based testing for both infectious and genetic diseases ... His core competency circles around ...

Genetic testing presents major growth opportunities in predictive diagnostics, pharmacogenomic testing, and direct-to-consumer markets. With increasing test volumes and lower prices, the industry is ...

According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...

Genetix Biotherapeutics Inc. today announced that an analysis of recent patient experience data from the commercial implementation of LYFGENIAtm and ZYNTEGLOtm in the U.S. has been selected for oral ...